Recent exciting developments include the formation of Xenometrics™, a Sinclair company launched in September of 2006. Xenometrics™ is dedicated to providing state of the art safety pharmacology studies. Xenometrics consists of an experienced safety pharmacology team led by a leading expert in the field and will offer studies designed to satisfy global guidelines that have to be met prior to first administration in humans.

These studies will comprise of:

1. Cardiovascular assessment in canines or primates by telemetry
2. In vitro electrophysiology studies
3. Respiratory assessment in rodents
4. CNS assessment in rodents
5. Drug metabolism and pharmacokinetics

Link to Xenometric website: http://www.xeno-metrics.com/